naturapharma ltd
naturapharma ltd Company Information
Company Number
08795060
Next Accounts
Nov 2025
Industry
Other retail sale not in stores, stalls or markets
Shareholders
zihao jin
qianqian jin
Group Structure
View All
Contact
Registered Address
124 city road, london, EC1V 2NX
Website
en.naturapharma.comnaturapharma ltd Estimated Valuation
Pomanda estimates the enterprise value of NATURAPHARMA LTD at £3.2m based on a Turnover of £8.5m and 0.37x industry multiple (adjusted for size and gross margin).
naturapharma ltd Estimated Valuation
Pomanda estimates the enterprise value of NATURAPHARMA LTD at £0 based on an EBITDA of £-169.1k and a 3.66x industry multiple (adjusted for size and gross margin).
naturapharma ltd Estimated Valuation
Pomanda estimates the enterprise value of NATURAPHARMA LTD at £1.1k based on Net Assets of £554 and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Naturapharma Ltd Overview
Naturapharma Ltd is a live company located in london, EC1V 2NX with a Companies House number of 08795060. It operates in the other retail sale not in stores, stalls or markets sector, SIC Code 47990. Founded in November 2013, it's largest shareholder is zihao jin with a 80% stake. Naturapharma Ltd is a established, mid sized company, Pomanda has estimated its turnover at £8.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Naturapharma Ltd Health Check
Pomanda's financial health check has awarded Naturapharma Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £8.5m, make it larger than the average company (£906.2k)
- Naturapharma Ltd
£906.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a slower rate (10.5%)
- Naturapharma Ltd
10.5% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Naturapharma Ltd
32.4% - Industry AVG
Profitability
an operating margin of -2.1% make it less profitable than the average company (4.6%)
- Naturapharma Ltd
4.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (8)
2 - Naturapharma Ltd
8 - Industry AVG
Pay Structure
on an average salary of £36.3k, the company has an equivalent pay structure (£36.3k)
- Naturapharma Ltd
£36.3k - Industry AVG
Efficiency
resulting in sales per employee of £4.2m, this is more efficient (£202.1k)
- Naturapharma Ltd
£202.1k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is later than average (32 days)
- Naturapharma Ltd
32 days - Industry AVG
Creditor Days
its suppliers are paid after 162 days, this is slower than average (36 days)
- Naturapharma Ltd
36 days - Industry AVG
Stock Days
it holds stock equivalent to 8 days, this is less than average (69 days)
- Naturapharma Ltd
69 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 28 weeks, this is average cash available to meet short term requirements (25 weeks)
28 weeks - Naturapharma Ltd
25 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a higher level of debt than the average (60.5%)
100% - Naturapharma Ltd
60.5% - Industry AVG
NATURAPHARMA LTD financials
Naturapharma Ltd's latest turnover from February 2024 is estimated at £8.5 million and the company has net assets of £554. According to their latest financial statements, Naturapharma Ltd has 2 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5,574,782 | 4,557,357 | |||||||||
| Other Income Or Grants | 0 | 0 | |||||||||
| Cost Of Sales | 5,413,334 | 4,072,489 | |||||||||
| Gross Profit | 161,448 | 484,868 | |||||||||
| Admin Expenses | 114,588 | 179,401 | |||||||||
| Operating Profit | 46,860 | 305,467 | |||||||||
| Interest Payable | 0 | 0 | |||||||||
| Interest Receivable | 0 | 0 | |||||||||
| Pre-Tax Profit | 46,860 | 305,467 | |||||||||
| Tax | -10,733 | -61,011 | |||||||||
| Profit After Tax | 36,127 | 244,456 | |||||||||
| Dividends Paid | 154,888 | 146,000 | |||||||||
| Retained Profit | -118,761 | 98,456 | |||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||
| EBITDA* | 47,620 | 306,481 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 41,049 | 11,917 | 14,836 | 5,752 | 2,282 | 3,042 | 2,689 | 1,039 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 41,049 | 11,917 | 14,836 | 5,752 | 2,282 | 3,042 | 2,689 | 1,039 | 0 | 0 | 0 |
| Stock & work in progress | 132,151 | 774,225 | 55,690 | 442,855 | 1,032,173 | 1,309,141 | 1,851,034 | 2,068,151 | 0 | 0 | 0 |
| Trade Debtors | 986,885 | 742,431 | 982,853 | 889,443 | 1,044,201 | 844,877 | 1,364,458 | 570,760 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 43,671 | 1,001 | 51,075 | 1,729 | 54,530 | 866,225 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1,411,035 | 2,035,681 | 1,379,042 | 878,809 | 1,889,881 | 906,573 | 666,251 | 860,024 | 100 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,573,742 | 3,553,338 | 2,468,660 | 2,212,836 | 4,020,785 | 3,926,816 | 3,881,743 | 3,498,935 | 100 | 0 | 0 |
| total assets | 2,614,791 | 3,565,255 | 2,483,496 | 2,218,588 | 4,023,067 | 3,929,858 | 3,884,432 | 3,499,974 | 100 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 2,548,621 | 3,397,352 | 2,448,896 | 2,005,591 | 3,956,090 | 3,522,679 | 3,607,472 | 3,538,494 | 253 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 171,862 | 152,729 | 154,637 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 65,616 | 81,921 | 31,734 | 70,072 | 17,549 | 67,128 | 54,498 | 0 | 0 | 0 | 0 |
| total current liabilities | 2,614,237 | 3,479,273 | 2,480,630 | 2,075,663 | 3,973,639 | 3,761,669 | 3,814,699 | 3,693,131 | 253 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 2,614,237 | 3,479,273 | 2,480,630 | 2,075,663 | 3,973,639 | 3,761,669 | 3,814,699 | 3,693,131 | 253 | 0 | 0 |
| net assets | 554 | 85,982 | 2,866 | 142,925 | 49,428 | 168,189 | 69,733 | -193,157 | -153 | 0 | 0 |
| total shareholders funds | 554 | 85,982 | 2,866 | 142,925 | 49,428 | 168,189 | 69,733 | -193,157 | -153 | 0 | 0 |
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | 46,860 | 305,467 | |||||||||
| Depreciation | 6,783 | 3,830 | 2,662 | 1,176 | 760 | 1,014 | 896 | 346 | 0 | ||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tax | -10,733 | -61,011 | |||||||||
| Stock | -642,074 | 718,535 | -387,165 | -589,318 | -276,968 | -541,893 | -217,117 | 2,068,151 | 0 | 0 | 0 |
| Debtors | 287,124 | -290,496 | 142,756 | -207,559 | -612,371 | 346,644 | 793,698 | 570,760 | 0 | 0 | 0 |
| Creditors | -848,731 | 948,456 | 443,305 | -1,950,499 | 433,411 | -84,793 | 68,978 | 3,538,241 | 253 | 0 | 0 |
| Accruals and Deferred Income | -16,305 | 50,187 | -38,338 | 52,523 | -49,579 | 12,630 | 54,498 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 1,310,058 | 368,556 | |||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | -171,862 | 19,133 | -1,908 | 154,637 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | 0 | 0 | |||||||||
| cash flow from financing | -171,862 | 19,133 | |||||||||
| cash and cash equivalents | |||||||||||
| cash | -624,646 | 656,639 | 500,233 | -1,011,072 | 983,308 | 240,322 | -193,773 | 859,924 | 100 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -624,646 | 656,639 | 500,233 | -1,011,072 | 983,308 | 240,322 | -193,773 | 859,924 | 100 | 0 | 0 |
naturapharma ltd Credit Report and Business Information
Naturapharma Ltd Competitor Analysis
Perform a competitor analysis for naturapharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in EC1V area or any other competitors across 12 key performance metrics.
naturapharma ltd Ownership
NATURAPHARMA LTD group structure
Naturapharma Ltd has no subsidiary companies.
Ultimate parent company
NATURAPHARMA LTD
08795060
naturapharma ltd directors
Naturapharma Ltd currently has 2 directors. The longest serving directors include Mr Zihao Jin (Nov 2013) and Mrs Qianqian Jin (Feb 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Zihao Jin | England | 50 years | Nov 2013 | - | Director |
| Mrs Qianqian Jin | England | 41 years | Feb 2017 | - | Director |
P&L
February 2024turnover
8.5m
-4%
operating profit
-175.9k
0%
gross margin
32.4%
-1.17%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
554
-0.99%
total assets
2.6m
-0.27%
cash
1.4m
-0.31%
net assets
Total assets minus all liabilities
naturapharma ltd company details
company number
08795060
Type
Private limited with Share Capital
industry
47990 - Other retail sale not in stores, stalls or markets
incorporation date
November 2013
age
11
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
February 2024
previous names
N/A
accountant
-
auditor
-
address
124 city road, london, EC1V 2NX
Bank
-
Legal Advisor
-
naturapharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to naturapharma ltd.
naturapharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
